It is a pharma private limited company based in Panchkula, Haryana, India, established in 2022.
2022 | Panchkula, Haryana, India | ActiveKesar Drugs Private Limited, a active private limited company, was established on 27 May 2022 in Panchkula, Haryana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24290HR2022PTC103991. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Saurabh Juneja (Director), Balinder Kumar (Director), Harishender Mohan (Director). Past directors included Saurabh Juneja, Neelam Garg, Balinder Kumar. It holds ₹16.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 112, Phase 1, Panchkula, Haryana, 134109.
U24290HR2022PTC103991
103991
27 May 2022
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Kesar Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saurabh Juneja | Director | 10 Oct 2022 | Current |
| Balinder Kumar | Director | 10 Oct 2022 | Current |
| Harishender Mohan | Director | 10 Oct 2022 | Current |
| Sajjan Kumar | Director | 27 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Dec 2023 | Past |
| Pramod Abcsdd | Director | 10 Oct 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Dec 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Kesar Drugs Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 4230% decrease in profit. The company's net worth observed a substantial decline by a decrease of 481.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
Unlock access to Kesar Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹160,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2023 | Hdfc Bank Limited | ₹16.00 Cr | Open |
Explore comprehensive loan charge details -
Kesar Drugs has a workforce of 0 employees as of Oct 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Kesar Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kesar Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Kesar Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity A charge with Hdfc Bank Limited of Rs. 160.00 M registered on 15 Jul 2023 with Charge ID 100787601 was modified on 04 Jul 2024. was completed.
The activity Kesar Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 160.00 M with Charge ID 100787601 was registered on 15 Jul 2023. was completed.
Saurabh Juneja was appointed as a Director was appointed as a Director on 10 Oct 2022 & has been associated with this company since 3 years 1 month . was recorded as a recent event.
Progress on Balinder Kumar was appointed as a Director was appointed as a Director on 10 Oct 2022 & has been associated with this company since 3 years 1 month . was documented.
The CIN of Kesar Drugs Private Limited is U24290HR2022PTC103991.
Kesar Drugs Private Limited is headquartered at Plot No. 112, Phase 1, Panchkula, Haryana, 134109.
Kesar Drugs Private Limited was incorporated on 27 May 2022.
The current directors of Kesar Drugs Private Limited are
The primary industry of Kesar Drugs Private Limited is Pharma.
Kesar Drugs Private Limited is unlisted.
The authorized capital of Kesar Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX